Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

BACKGROUND: Cumulative evidence from epidemiological, preclinical and clinical studies suggests estrogens may have psychoprotective effects in schizophrenic patients. Selective Estrogen Receptor Modulators could have therapeutic benefits in schizophrenia for both sexes without being hazardous to gyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Kianimehr, Gilda, Fatehi, Farzad, Hashempoor, Sara, Khodaei-Ardakani, Mohammad-Reza, Rezaei, Farzin, Nazari, Ali, Kashani, Ladan, Akhondzadeh, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100751/
https://www.ncbi.nlm.nih.gov/pubmed/25012765
http://dx.doi.org/10.1186/2008-2231-22-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100751/
https://www.ncbi.nlm.nih.gov/pubmed/25012765
http://dx.doi.org/10.1186/2008-2231-22-55

Ejemplares similares